应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BCDA BioCardia
休市中 07-05 16:00:00 EDT
2.97
-0.02
-0.67%
盘后
2.97
+0.00
0.00%
19:32 EDT
最高
3.10
最低
2.80
成交量
3.65万
今开
3.06
昨收
2.99
日振幅
10.03%
总市值
542.18万
流通市值
358.89万
总股本
182.55万
成交额
10.76万
换手率
3.02%
流通股本
120.84万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Biocardia, Inc.盘中异动 下午盘股价大跌6.35%
自选股智能写手 · 07-06 01:14
Biocardia, Inc.盘中异动 下午盘股价大跌6.35%
Biocardia, Inc.盘中异动 快速上涨8.50%
自选股智能写手 · 07-03
Biocardia, Inc.盘中异动 快速上涨8.50%
Biocardia, Inc.盘中异动 下午盘快速上涨6.55%
自选股智能写手 · 06-28
Biocardia, Inc.盘中异动 下午盘快速上涨6.55%
Biocardia, Inc.盘中异动 股价大跌7.17%
自选股智能写手 · 06-27
Biocardia, Inc.盘中异动 股价大跌7.17%
Biocardia, Inc.盘中异动 早盘股价大涨6.36%
自选股智能写手 · 06-25
Biocardia, Inc.盘中异动 早盘股价大涨6.36%
Biocardia, Inc.盘中异动 快速拉升6.87%报3.21美元
自选股智能写手 · 06-24
Biocardia, Inc.盘中异动 快速拉升6.87%报3.21美元
Biocardia, Inc.盘中异动 早盘股价大跌5.62%报3.34美元
自选股智能写手 · 06-20
Biocardia, Inc.盘中异动 早盘股价大跌5.62%报3.34美元
Biocardia, Inc.盘中异动 下午盘股价大涨5.42%
自选股智能写手 · 06-12
Biocardia, Inc.盘中异动 下午盘股价大涨5.42%
Biocardia, Inc.盘中异动 早盘股价大跌9.68%
自选股智能写手 · 06-10
Biocardia, Inc.盘中异动 早盘股价大跌9.68%
BUZZ-BioCardia 因获得美国心脏设备专利而大涨
Reuters · 06-07
BUZZ-BioCardia 因获得美国心脏设备专利而大涨
Biocardia, Inc.盘中异动 早盘股价大涨5.43%报4.66美元
自选股智能写手 · 06-05
Biocardia, Inc.盘中异动 早盘股价大涨5.43%报4.66美元
Biocardia, Inc.盘中异动 早盘股价大涨12.54%
自选股智能写手 · 05-23
Biocardia, Inc.盘中异动 早盘股价大涨12.54%
Biocardia, Inc.盘中异动 股价大跌7.02%
自选股智能写手 · 05-22
Biocardia, Inc.盘中异动 股价大跌7.02%
Biocardia, Inc.盘中异动 股价大涨5.26%报0.400美元
自选股智能写手 · 05-06
Biocardia, Inc.盘中异动 股价大涨5.26%报0.400美元
Biocardia, Inc.盘中异动 早盘大幅拉升5.38%
自选股智能写手 · 04-30
Biocardia, Inc.盘中异动 早盘大幅拉升5.38%
Biocardia, Inc.盘中异动 急速跳水5.10%报0.370美元
自选股智能写手 · 04-16
Biocardia, Inc.盘中异动 急速跳水5.10%报0.370美元
Biocardia, Inc.盘中异动 早盘股价大跌5.10%
自选股智能写手 · 04-11
Biocardia, Inc.盘中异动 早盘股价大跌5.10%
Biocardia, Inc.2023财年实现净利润-11.57百万美元,同比增加2.85%
自选股智能写手 · 03-28
Biocardia, Inc.2023财年实现净利润-11.57百万美元,同比增加2.85%
BioCardia Inc 预计每股亏损11美分 - 财报前瞻
Reuters · 03-26
BioCardia Inc 预计每股亏损11美分 - 财报前瞻
加载更多
公司概况
公司名称:
BioCardia
所属市场:
NASDAQ
上市日期:
--
主营业务:
Biocardia, Inc.于1994年1月12日在特拉华州注册成立。该公司是一家临床阶段的再生医学公司,为具有大量未满足的医疗需求的心血管疾病开发新的治疗药物。他们的主要治疗候选药物是研究性CardiAMP细胞治疗系统,该系统提供自体骨髓衍生细胞疗法(使用患者自身细胞)治疗两种临床适应症:心脏病发作和慢性心肌缺血后发生的心力衰竭。
发行价格:
--
{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":2.97,"timestamp":1720209600000,"preClose":2.99,"halted":0,"volume":36466,"hourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"19:32 EDT","volume":93,"amount":273.42,"timestamp":1720222363306},"delay":0,"floatShares":1208400,"shares":1825506,"eps":-6.9603,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"07-05 16:00:00 EDT","open":3.06,"high":3.1,"low":2.8,"amount":107553.7393432,"amplitude":0.100334,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.9603,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720425600000},"adr":0,"adjPreClose":2.99,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"19:32 EDT","volume":93,"amount":273.42,"timestamp":1720222363306},"volumeRatio":1.2605518488379601,"impliedVol":0.8044,"impliedVolPercentile":0.3391},"requestUrl":"/m/hq/s/BCDA","defaultTab":"news","newsList":[{"id":"2449290244","title":"Biocardia, Inc.盘中异动 下午盘股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449290244","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449290244?lang=zh_cn&edition=full","pubTime":"2024-07-06 01:14","pubTimestamp":1720199695,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日01时14分,Biocardia, Inc.股票出现波动,股价快速跳水6.35%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为1.25%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。消息层面,截至01时14分,《BioCardia董事增持500股普通股股份,价值约1,513美元》资讯为影响Biocardia, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706011455941f47b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706011455941f47b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2448884934","title":"Biocardia, Inc.盘中异动 快速上涨8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448884934","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448884934?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013513,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分,Biocardia, Inc.股票出现异动,股价大幅拉升8.50%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。消息层面,截至21时31分,《BioCardia董事增持500股普通股股份,价值约1,513美元》资讯为影响Biocardia, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131539efc1b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407032131539efc1b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2446569374","title":"Biocardia, Inc.盘中异动 下午盘快速上涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446569374","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446569374?lang=zh_cn&edition=full","pubTime":"2024-06-28 02:09","pubTimestamp":1719511757,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日02时09分,Biocardia, Inc.股票出现波动,股价大幅上涨6.55%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Kala Bio, Inc.涨幅较大,Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2876.36%、382.67%、355.22%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.,振幅分别为322.04%、127.05%、92.99%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628020917af8f8de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628020917af8f8de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2446315268","title":"Biocardia, Inc.盘中异动 股价大跌7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446315268","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446315268?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:42","pubTimestamp":1719420169,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时42分,Biocardia, Inc.股票出现异动,股价急速下挫7.17%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,Anew Medical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为678.28%、155.34%、109.78%,振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为112.12%、51.85%、45.14%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627004250941f170b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627004250941f170b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2446474088","title":"Biocardia, Inc.盘中异动 早盘股价大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446474088","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446474088?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:40","pubTimestamp":1719326422,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时40分,Biocardia, Inc.股票出现异动,股价大幅拉升6.36%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为1.38%。其相关个股中,Cns Pharmaceuticals, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Glycomimetics, Inc.涨幅较大,Effector Therapeutics, Inc.、Glycomimetics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为182.21%、153.41%、117.29%,振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.、Effector Therapeutics, Inc.,振幅分别为67.71%、37.88%、34.24%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522402396816a84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062522402396816a84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2445072651","title":"Biocardia, Inc.盘中异动 快速拉升6.87%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445072651","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445072651?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:33","pubTimestamp":1719236009,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时33分,Biocardia, Inc.股票出现异动,股价大幅上涨6.87%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,Revelation Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大,Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃,换手率分别为458.05%、45.63%、35.73%,振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.、Geovax Labs, Inc.,振幅分别为37.57%、29.86%、18.45%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213329968163d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624213329968163d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2444288214","title":"Biocardia, Inc.盘中异动 早盘股价大跌5.62%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444288214","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444288214?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:36","pubTimestamp":1718890594,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时36分,Biocardia, Inc.股票出现波动,股价大幅下跌5.62%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃,换手率分别为358.45%、154.41%、125.75%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Clearmind Medicine Inc.,振幅分别为65244.36%、30.23%、24.39%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213635aef5da60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213635aef5da60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2442431041","title":"Biocardia, Inc.盘中异动 下午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442431041","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442431041?lang=zh_cn&edition=full","pubTime":"2024-06-12 02:06","pubTimestamp":1718129178,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日02时06分,Biocardia, Inc.股票出现异动,股价急速上涨5.42%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612020618968136d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612020618968136d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2442267842","title":"Biocardia, Inc.盘中异动 早盘股价大跌9.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442267842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442267842?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:32","pubTimestamp":1718026336,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时32分,Biocardia, Inc.股票出现异动,股价快速下跌9.68%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Surrozen Inc C/Wts 01/08/2031 、Dermata Therapeutics Inc C/Wts 涨幅较大,Hoth Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为34.47%、30.86%、29.56%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Gain Therapeutics, Inc.、Calidi Biotherapeutics, Inc.,振幅分别为86.12%、16.82%、12.38%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102132169f2ccb03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102132169f2ccb03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2441063172","title":"BUZZ-BioCardia 因获得美国心脏设备专利而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441063172","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441063172?lang=zh_cn&edition=full","pubTime":"2024-06-07 20:57","pubTimestamp":1717765031,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月7日 - ** 细胞疗法开发商 BioCardia 的股价盘前上涨 17.3% 至 5.12 美元 ** 公司称已获得其心脏设备的美国专利,该专利将于2036年到期 ** 该专利与桡动脉输送系统有关,通过该系统可将心脏导管穿过病人手腕上的血管,对心脏进行治疗。 ** 该公司称,其输送系统旨在通过在输送过程中与心脏组织稳定、安全地接触,防止治疗药物泄漏** 截至上次收盘,该公司股价年累计下跌 56.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BUZZ","BK4139"],"gpt_icon":0},{"id":"2441627168","title":"Biocardia, Inc.盘中异动 早盘股价大涨5.43%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441627168","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441627168?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:41","pubTimestamp":1717594863,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时41分,Biocardia, Inc.股票出现波动,股价快速上涨5.43%。截至发稿,该股报4.66美元/股,成交量1779股,换手率0.10%,振幅4.52%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214103959154a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214103959154a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2437757895","title":"Biocardia, Inc.盘中异动 早盘股价大涨12.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437757895","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437757895?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:31","pubTimestamp":1716471084,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日21时31分,Biocardia, Inc.股票出现波动,股价急速拉升12.54%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Altamira Therapeutics Ltd.、Serina Therapeutics, Inc.涨幅较大,Altamira Therapeutics Ltd.、Theriva Biologics, Inc.、Mustang Bio, Inc.较为活跃,换手率分别为296.93%、77.95%、31.90%,振幅较大的相关个股有Geovax Labs, Inc.、Altamira Therapeutics Ltd.、Theriva Biologics, Inc.,振幅分别为14.44%、12.59%、9.20%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405232131249edd671f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405232131249edd671f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2437951392","title":"Biocardia, Inc.盘中异动 股价大跌7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437951392","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437951392?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384677,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分,Biocardia, Inc.股票出现波动,股价急速跳水7.02%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rezolute, Inc.、Mustang Bio, Inc.涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为183.44%、88.21%、32.28%,振幅较大的相关个股有Nutriband Inc C/Wts 、Eupraxia Pharmaceuticals Inc.、Avalo Therapeutics, Inc.,振幅分别为12.90%、8.33%、7.60%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221311895503dfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221311895503dfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2433040351","title":"Biocardia, Inc.盘中异动 股价大涨5.26%报0.400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433040351","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433040351?lang=zh_cn&edition=full","pubTime":"2024-05-06 23:00","pubTimestamp":1715007623,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日23时00分,Biocardia, Inc.股票出现波动,股价快速上涨5.26%。截至发稿,该股报0.400美元/股,成交量5.2319万股,换手率0.19%,振幅5.76%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050623002387e85daa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050623002387e85daa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2431326158","title":"Biocardia, Inc.盘中异动 早盘大幅拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431326158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431326158?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:33","pubTimestamp":1714483989,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时33分,Biocardia, Inc.股票出现波动,股价大幅上涨5.38%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Senti Biosciences, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大,Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为524.21%、167.59%、7.93%,振幅较大的相关个股有Senti Biosciences, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为24.41%、12.82%、10.41%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021330987c3f72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021330987c3f72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2427833496","title":"Biocardia, Inc.盘中异动 急速跳水5.10%报0.370美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427833496","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427833496?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:45","pubTimestamp":1713210346,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日03时45分,Biocardia, Inc.股票出现波动,股价快速下跌5.10%。截至发稿,该股报0.370美元/股,成交量10.5877万股,换手率0.40%,振幅6.87%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大,Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1673.39%、1261.06%、902.00%,振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为273.33%、124.89%、80.04%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段的再生医学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160345467920a733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160345467920a733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2426261763","title":"Biocardia, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426261763","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426261763?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:18","pubTimestamp":1712848699,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时18分,Biocardia, Inc.股票出现异动,股价快速下跌5.10%。截至发稿,该股报0.380美元/股,成交量3.6152万股,换手率0.14%,振幅4.73%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.76%。其相关个股中,Rallybio Corporation、Eliem Therapeutics, Inc、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大,Adial Pharmaceuticals, Inc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃,换手率分别为649.92%、484.95%、466.10%,振幅较大的相关个股有Rallybio Corporation、Tc Biopharm Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为50.92%、46.31%、40.90%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段的再生医学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112318197a522fcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112318197a522fcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2422111305","title":"Biocardia, Inc.2023财年实现净利润-11.57百万美元,同比增加2.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422111305","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422111305?lang=zh_cn&edition=full","pubTime":"2024-03-28 23:13","pubTimestamp":1711638838,"startTime":"0","endTime":"0","summary":"12月31日,Biocardia, Inc.公布财报,公告显示公司2023财年净利润为-11.57百万美元,同比增加2.85%;其中营业收入为477000.00美元,同比减少64.67%,每股基本收益为-0.55美元。从资产负债表来看,Biocardia, Inc.总负债4.59百万美元,其中短期债务333000.00美元,资产负债比为0.66,流动比率为0.41。机构评级:截至2023年12月31日,当前有1家机构对Biocardia, Inc.目标价做出预测,其中目标均价为4.00美元,其中最低目标价为4.00美元,最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282314058b6e45a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403282314058b6e45a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA"],"gpt_icon":0},{"id":"2422575444","title":"BioCardia Inc 预计每股亏损11美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422575444","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422575444?lang=zh_cn&edition=full","pubTime":"2024-03-26 04:26","pubTimestamp":1711398371,"startTime":"0","endTime":"0","summary":" * BioCardia Inc 将于3月27日公布截至2023年12月31日的季度财报,预计该公司的季度收入将出现下降。* LSEG 分析师对 BioCardia Inc 的平均预期是每股亏损 11 美分。* 华尔街对 BioCardia Inc 的 12 个月目标价中位数为 4.00 美元,高于上一次 0.41 美元的收盘价。3月25日 - 本摘要于北京时间 3 月 25 日 20:26 机器生成。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.325},{"period":"3month","weight":-0.4864},{"period":"6month","weight":-0.6951},{"period":"1year","weight":-0.9256},{"period":"ytd","weight":-0.7019}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.1853},{"period":"1year","weight":0.2615},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biocardia, Inc.于1994年1月12日在特拉华州注册成立。该公司是一家临床阶段的再生医学公司,为具有大量未满足的医疗需求的心血管疾病开发新的治疗药物。他们的主要治疗候选药物是研究性CardiAMP细胞治疗系统,该系统提供自体骨髓衍生细胞疗法(使用患者自身细胞)治疗两种临床适应症:心脏病发作和慢性心肌缺血后发生的心力衰竭。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.06938},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000116},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.063445},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020094},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.051537},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.041157},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.034599},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.126545},{"month":9,"riseRate":0.333333,"avgChangeRate":0.0658},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.037787},{"month":11,"riseRate":0.5,"avgChangeRate":0.054404},{"month":12,"riseRate":0.5,"avgChangeRate":0.01405}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}